Exelixis to close Pennsylvania site, lay off 130 staffersnews2025-08-27T19:07:09+00:00August 27th, 2025|Endpoints News|
Indivior to reduce headcount, real estate in first stage of broader reorgnews2025-08-27T15:28:19+00:00August 27th, 2025|Endpoints News|
BioXcel to seek label update for psych drug Igalmi after Phase 3 successnews2025-08-27T11:00:24+00:00August 27th, 2025|Endpoints News|
US officials link tariffs with drug pricing talksnews2025-08-26T19:53:10+00:00August 26th, 2025|Endpoints News|
PhRMA loses fight over Oregon drug price transparency lawnews2025-08-26T19:37:40+00:00August 26th, 2025|Endpoints News|
Sanofi hires Novartis veteran as chief medical officernews2025-08-26T17:28:03+00:00August 26th, 2025|Endpoints News|
Novartis pays $30M to Leqembi creator for access to blood-brain barrier technews2025-08-26T15:05:22+00:00August 26th, 2025|Endpoints News|
Lilly plans GLP-1 pill filing after trial success in obesity and diabetesnews2025-08-26T10:45:53+00:00August 26th, 2025|Endpoints News|
HHS winds down decades-old pediatric brain cancer collaborationnews2025-08-25T19:39:28+00:00August 25th, 2025|Endpoints News|
